Clinical Trial Update: Umbilical Cord-derived Mesenchymal Stem Cell Infusion in the Management of Adult Liver Cirrhosis [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating infusion of umbilical cord-derived mesenchymal stem cells for adult liver cirrhosis; the study program has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis

Drugs mentioned

• Umbilical Cord-derived Mesenchymal Stem Cell Infusion (umbilical cord-derived mesenchymal stem cells)

Snippet

Sponsor: Vinmec Research Institute of Stem Cell and Gene Technology | Conditions: Liver Cirrhosis | Phase 1 | Status: COMPLETED